Schweizerische Padiatrische Onkologie Gruppe (spog)

What Schweizerische Padiatrische Onkologie Gruppe (spog) does

Schweizerische Pädiatrische Onkologie Gruppe (SPOG) is a Swiss non-profit association (Verein) founded in 1976 and headquartered in Bern at Effingerstrasse 33. The organization is the national coordinator of clinical pediatric oncology research in Switzerland, linking nine member clinics located in Basel, Aarau, Zürich, St. Gallen, Bellinzona, Luzern, Bern, Lausanne, and Geneva. SPOG does not sell products or services; instead, it coordinates clinical studies, maintains a Patient Advisory Board, and publishes research insights to improve treatment outcomes and quality of life for children and adolescents with cancer and blood diseases. Swiss pediatric cancer survival rates stand at over 87%, with over 90% survival for acute lymphoblastic leukemia, compared with near-universal mortality in 1972.

SPOG's core operations center on multi-site clinical trial coordination, international research collaboration, and public engagement around childhood cancer. The organization maintains affiliations with SIOP (International Society of Paediatric Oncology), PanCare, and SIOPEN, and participates in the Swiss National Research Priority 'Children and Cancer.' Its digital footprint consists of an informational website (spog.ch), a member login portal, newsletter subscriptions, and downloadable resources including annual reports and the 'Chronik der Hoffnung' chronicle. The organization operates with a headcount band of 11-50 employees and is governed by a board chaired by Präsidentin Katrin Scheinemann, with Vizepräsident Nicolas Gerber serving as national study leader and Direktorin Isabelle Lamontagne-Müller leading the coordinating centre.

SPOG's revenue model is donation-based, combining individual contributions (suggested tiers of 60, 120, and 180 CHF), corporate and foundation sponsorships (e.g., Kinderkrebs Schweiz, Norgine AG, Krebsliga Schweiz, Krebsforschung Schweiz, Zoé4life, Recordati AG, Interpharma, Ipsen, Lipomed AG), and long-term government grants from the State Secretariat for Education, Research and Innovation (SBFI). In 2026, the organization celebrated its 50th anniversary with a jubilee symposium in Bern attended by approximately 200 stakeholders, a movement-based fundraising campaign ('Gemeinsam in Bewegung für krebskranke Kinder'), and participation in three international conferences (SIOP 2026 in San Antonio, PanCare Basel 2026, SIOPEN 2026 in Rome). Financial figures are not publicly disclosed.

Name

Schweizerische Padiatrische Onkologie Gruppe (spog)

Legal name

Schweizerische Pädiatrische Onkologie Gruppe SPOG

Website

https://spog.ch

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

11–50 employees

Short description

SPOG is a Swiss non-profit association founded in 1976 that coordinates national clinical pediatric oncology research across nine member clinics in Switzerland, serving children and adolescents with cancer and blood diseases through international research collaboration and donation-based funding.

Ownership category

akta.pro rank

Product category

Pediatric Oncology Clinical Research

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Pediatric oncology research
• Clinical trial coordination
• Childhood cancer studies
• Hemato-oncology research
• Nonprofit research network

Headquarters

HQ city

Bern

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Donations and Fundraising: SPOG raises funds from individual donors, with suggested donation amounts of 60 CHF, 120 CHF, and 180 CHF. The organization also conducts dedicated fundraising campaigns such as the 50th anniversary movement campaign 'Gemeinsam in Bewegung für krebskranke Kinder'.
2. Corporate and Foundation Sponsorships: SPOG receives financial support from corporate sponsors and foundations. Gold sponsor Kinderkrebs Schweiz, Silver sponsor Norgine AG, Bronze sponsors including Krebsliga Schweiz, Krebsforschung Schweiz, Zoé4life, Recordati AG, Interpharma, Brunello Gianella, Ipsen, and Special sponsor Lipomed AG supported the 50th anniversary symposium.
3. Government Funding: SPOG receives long-term financial support from the State Secretariat for Education, Research and Innovation (SBFI) as recognition of its scientific work in pediatric oncology research.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

SPOG coordinates clinical pediatric oncology and hematology research studies across Switzerland, operating a national network of nine member clinics that conduct and participate in clinical trials for children and adolescents with cancer and blood diseases. The organization functions as a non-profit research association, providing study coordination, research collaboration, and a Patient Advisory Board, while raising funds through donations, sponsorships, and government support.

Product overview

SPOG is a Swiss nonprofit association (Verein) dedicated to clinical pediatric oncology research, not a technology product company. It coordinates nine member clinics across Switzerland for childhood cancer research and operates a coordinating centre. The organization provides study coordination, research collaboration, patient advisory services, and public education about pediatric cancer. Its digital presence consists of an informational website, fundraising tools, and downloadable resources including annual reports, publications, and organizational documents.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Study Coordination
• SPOG Study Portfolio
• Patient Advisory Board

Quantifiable outcome

• Over 87% survival rate for children with cancer in Switzerland
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered gold sponsor, bronze sponsor and core.

• Kinderkrebs Schweiz (Childhood Cancer Switzerland)gold sponsorStrategic or Co-development PartnerKinderkrebs Schweiz is a Gold-level sponsor of SPOG's activities and a key strategic partner in childhood cancer advocacy in Switzerland. The organization is represented on SPOG's board by National Councilor Manuela Weichelt.
• Krebsliga Schweiz (Swiss Cancer League)bronze sponsorStrategic or Co-development PartnerKrebsliga Schweiz is a Bronze-level sponsor of SPOG's 50th anniversary symposium, supporting the organization's mission in pediatric cancer research.
• Krebsforschung Schweiz (Swiss Cancer Research)bronze sponsorStrategic or Co-development PartnerKrebsforschung Schweiz is a Bronze-level sponsor supporting SPOG's research activities.
• SIOP (International Society of Paediatric Oncology)coreStrategic or Co-development PartnerSPOG collaborates with SIOP as the global professional society for pediatric oncology. The organization's founding father Hans-Peter Wagner initiated a committee within SIOP in 1993 to help countries with limited resources improve cancer treatment in children.
• PanCarecoreStrategic or Co-development PartnerSPOG collaborates with PanCare, a European network for survivors of childhood and adolescent cancer, working together on issues of survivorship and late effects of treatment.
• SIOPEN (European Society for Paediatric Oncology)coreStrategic or Co-development PartnerSPOG participates in SIOPEN Annual General Meetings, collaborating on European pediatric oncology research initiatives.
• National Research Priority 'Children and Cancer'coreStrategic or Co-development PartnerThis national research priority enables SPOG to better understand the biology of childhood cancers and develop new tailored therapies, representing a major collaborative research initiative.
• Nine Member Clinics (Basel, Aarau, Zürich, St. Gallen, Bellinzona, Luzern, Bern, Lausanne, Geneva)coreStrategic or Co-development PartnerSPOG coordinates clinical pediatric oncology research through a network of nine member clinics across Switzerland, representing all major pediatric oncology centers in the country.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• PanCare: European multidisciplinary network focused on survivorship and late effects of childhood and adolescent cancer treatment. It is a thematic peer and existing SPOG partner addressing the post-treatment dimension of pediatric oncology care.
• International Society of Paediatric Oncology (SIOP): Global professional society for pediatric oncology that SPOG partners with. While it operates at a global rather than national level, SIOP sets the international frameworks within which SPOG-coordinated studies are designed and run.
• SIOPEN (European Society for Paediatric Oncology): European network coordinating pediatric oncology clinical trials across multiple European countries. It is a broader regional peer that SPOG participates in, rather than a direct competitor, with overlapping but more specialized scope in neuroblastoma and rare tumors.

Direct peers

• NOPHO (Nordic Society of Paediatric Haematology and Oncology): Nordic multi-country collaborative that coordinates pediatric hematology and oncology clinical research across Scandinavian countries. It is a regional analog to SPOG's national coordination model.
• Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH): German professional society coordinating pediatric oncology and hematology research and treatment across Germany. It is the closest geographic and structural peer to SPOG in the DACH region.
• Children's Oncology Group (COG): The largest pediatric oncology clinical research cooperative in the world, coordinating clinical trials across more than 200 US institutions. It is the most direct functional analog to SPOG in terms of national-level clinical study coordination in pediatric oncology.
• Children's Cancer and Leukaemia Group (CCLG): UK-based organization that coordinates pediatric cancer clinical research across British and Irish treatment centers. It mirrors SPOG's role of a national clinical trial coordination body for pediatric oncology and hematology.
• Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'adolescent (SFCE): French national network coordinating pediatric oncology clinical trials and treatment protocols across French centers. It plays an analogous national coordination role to SPOG within France.
• Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP): Italian national association coordinating pediatric hematology and oncology research across Italian centers. It is functionally comparable to SPOG as a national pediatric oncology study coordinator within a European country.
• C17 Council (Canadian Pediatric Oncology Group): Canadian national network coordinating pediatric oncology clinical trials across all Canadian pediatric cancer centers. It directly parallels SPOG in role and structure as a national pediatric oncology research coordinator.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Schweizerische Padiatrische Onkologie Gruppe (spog)